Monday, June 15, 2026

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Luxury Vs. Famine: North Korea’s Elite Rush To Buy $100 Labubu Toys In The Land Of The Dead

North Korea's Future Reserve café mimics Starbucks, offering Labubu vouchers requiring 100 coffee purchases for redemption.

Galaxy S22 Owners Just Lost Their Lawsuit Against Samsung

Galaxy S22 users lost a lawsuit against Samsung over performance issues linked to the Game Optimizing Service, dismissed by the court.

Tag: Chongjin Shipyard

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.